Forest Baskett - Oct 18, 2021 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
10%+ Owner
Signature
/s/ Sasha Keough, attorney-in-fact
Stock symbol
TRVI
Transactions as of
Oct 18, 2021
Transactions value $
$0
Form type
4
Date filed
10/19/2021, 09:10 PM
Previous filing
Aug 13, 2021
Next filing
Oct 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction TRVI Common Stock Purchase +1.85M +31.19% 7.79M Oct 18, 2021 See Note 2 F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRVI 3.5-Year Common Stock Warrant Purchase +1.85M 1.85M Oct 18, 2021 Common Stock 1.85M $1.37 See Note 2 F1, F2
transaction TRVI 7-Year Common Stock Warrant Purchase +1.85M 1.85M Oct 18, 2021 Common Stock 1.85M $1.37 See Note 2 F1, F2

Explanation of Responses:

Id Content
F1 Represents securities acquired pursuant to a Securities Purchase Agreement (the "SPA"), dated October 15, 2021, by and between the Issuer and New Enterprise Associates 16, L.P. ("NEA 16"), with a closing on October 18, 2021. Pursuant to the terms of the SPA, NEA 16 purchased common units for $1.62 per common unit. Each common unit consisted of one share of the Issuer's common stock, one 3.5 year common stock warrant, and one 7-year common stock warrant.
F2 The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of NEA 16, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.